Dr. Elizabeth Roth, M.D

NPI: 1982925327
Total Payments
$1,581
2022 Payments
$30.81
Companies
4
Transactions
10

Payment Breakdown by Category

Travel$925.27 (58.5%)
Food & Beverage$406.00 (25.7%)
Research$243.76 (15.4%)
Education$6.08 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $925.27 2 58.5%
Food and Beverage $406.00 4 25.7%
Unspecified $243.76 1 15.4%
Education $6.08 3 0.4%

Payments by Type

General
$1,337
9 transactions
Research
$243.76
1 transactions

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $1,393 5 $0 (2017)
Davol Inc. $151.32 1 $0 (2017)
180 Medical, Inc. $30.81 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $30.81 1 180 Medical, Inc. ($30.81)
2021 $6.08 3 Travere Therapeutics, Inc. ($6.08)
2017 $1,544 6 Allergan Inc. ($1,393)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/08/2022 180 Medical, Inc. Food and Beverage In-kind items and services $30.81 General
04/22/2021 Travere Therapeutics, Inc. Thiola (Drug) Education In-kind items and services $2.49 General
Category: Kidney Stones
02/25/2021 Travere Therapeutics, Inc. Thiola (Drug) Education In-kind items and services $2.49 General
Category: Kidney Stones
02/25/2021 Travere Therapeutics, Inc. Thiola (Drug) Education In-kind items and services $1.10 General
Category: Kidney Stones
10/17/2017 Davol Inc. DAV-Arista AH (Device) Food and Beverage Cash or cash equivalent $151.32 General
Category: Surgical
05/18/2017 Allergan Inc. In-kind items and services $243.76 Research
Study: A TWO-PART, MULTICENTER, DOSE-TITRATION STUDY EVALUATING THE EFFICACY, SAFETY, PHARMACODYNAMICS, AND PHARMACOKINETICS OF OXYBUTYNINCHLORIDE 10 GEL FOR THE TREATMENT OF DETRUSOR OVERACTIVITY ASSOCIATED WITH A NEUROLOGICAL CONDITION IN PEDIATRIC PATIENTS
03/31/2017 Allergan Inc. Travel and Lodging In-kind items and services $618.26 General
03/31/2017 Allergan Inc. Travel and Lodging In-kind items and services $307.01 General
03/31/2017 Allergan Inc. Food and Beverage In-kind items and services $189.08 General
03/30/2017 Allergan Inc. Food and Beverage In-kind items and services $34.79 General

Research Studies & Clinical Trials

Study Name Company Amount Records
A TWO-PART, MULTICENTER, DOSE-TITRATION STUDY EVALUATING THE EFFICACY, SAFETY, PHARMACODYNAMICS, AND PHARMACOKINETICS OF OXYBUTYNINCHLORIDE 10 GEL FOR THE TREATMENT OF DETRUSOR OVERACTIVITY ASSOCIATED WITH A NEUROLOGICAL CONDITION IN PEDIATRIC PATIENTS Allergan Inc. $243.76 1

About Dr. Elizabeth Roth, M.D

Dr. Elizabeth Roth, M.D is a Urology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982925327.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Roth, M.D has received a total of $1,581 in payments from pharmaceutical and medical device companies, with $30.81 received in 2022. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($925.27).

Practice Information

  • Specialty Urology
  • Other Specialties Pediatric Urology
  • Location Milwaukee, WI
  • Active Since 06/21/2010
  • Last Updated 07/13/2023
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1982925327

Products in Payments

  • DAV-Arista AH (Device) $151.32
  • Thiola (Drug) $6.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Milwaukee